Conmed Corp expected to post earnings of 60  cents a share - Earnings Preview

Conmed

25/04/2023 24:24

* Conmed Corp  CNMD.N   CNMD.K  is expected to show a rise
in
quarterly revenue when it reports  results on April 26. 
    * The Largo Florida-based  company is expected to report  a
10.0% increase in revenue to $266.67 million from $242.33
million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data. The company's guidance on
February 2 2023, for the period ended March 31, was for revenue
between $262.00 million and $272.00 million.
    * ​Refinitiv's mean analyst estimate for Conmed Corp is for
earnings of 60 cents per share. The company's EPS guidance on
February 2 2023, for the period ended March 31, was between
$0.58 and $0.63 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Conmed Corp
is
$113.5​, below​ its last closing price of $117.33. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  0.89        0.90       0.42      Missed  -53.5
 Sep. 30 2022  0.75        0.75       0.77      Beat    2.4
 Jun. 30 2022  0.74        0.75       0.76      Beat    1.8​
 Mar. 31 2022  0.62        0.62       0.70      Beat    13.3
 ​​Dec.        1.03        1.03       1.07      Beat    4
 31 2021                                                
 Sep. 30 2021  0.75        0.75       0.80      Beat    6.7​
 Jun. 30 2021  0.62        0.62       0.71      Beat    14.5
 Mar. 31 2021  0.44        0.44       0.63      Beat    44.3
 This summary was machine generated April 24 at 23:24 GMT.  All
figures in US dollars  unless otherwise stated